| Abstrakt: |
A recent report from Sefako Makgatho Health Sciences University discusses the development of new radiopharmaceuticals for imaging bacterial infections. The researchers highlight the importance of accurate diagnosis and identification of infections, especially in the context of antimicrobial resistance. Molecular imaging using nuclear medicine allows for early detection and monitoring of infections. The report summarizes the most significant discoveries in bacterial infection imaging agents over the past five years, including radiolabelled bacterial siderophores and antimicrobial peptides. While progress has been made in preclinical investigations, the translation to clinical trials and practice has been slow. The authors emphasize the need for well-designed clinical investigations to evaluate the true potential of these new imaging agents. [Extracted from the article] |
